Molecular docking analysis reveals differential binding affinities of multiple classes of selective inhibitors towards cancer-associated KRAS mutants.
Sai Charitha MullaguriSravani AkulaPartha Sarathi SahooVigneshwar Reddy AshireddygariVyshnavika MupparapuRavalika SilveriV L S Prasad BurraRama Krishna KanchaPublished in: 3 Biotech (2022)
The online version contains supplementary material available at 10.1007/s13205-022-03407-9.